Explore Our Publications
Entrada’s commitment to publications & transparency
Entrada is committed to publishing the results of our sponsored research in a transparent, scientifically accurate, and timely manner. Entrada will apply high ethical standards to our publications and presentations and will adhere to recognized industry guidance such as International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and International Society for Medical Publication Professionals (ISMPP) Good Publication Practice for Communicating Company Sponsored Medical Research.
Past Presentations
-
Durable Exon Skipping and Dystrophin Production with Endosomal Escape Vehicle (EEV™) - Oligonucleotide Conjugates in Preclinical Models of DMD
- By: Jia Qi Cheng Zhang, PhD, Scientist, Neuromuscular, Entrada Therapeutics
- At: 2024 New Directions in Biology and Disease of Skeletal Muscle Conference
- On: June 23, 2024
DownloadJune 23, 2024 -
Optimization and Application of the Endosomal Escape Vehicle (EEV™) Platform for Enhanced Delivery of Oligonucleotides to Skeletal and Cardiac Muscle
- By: Mahboubeh Kheirabadi, PhD, Director, Discovery Chemistry, Entrada Therapeutics
- At: Cell-Penetrating Peptides: Next Generation Delivery Systems Conference
- On: June 11, 2024
DownloadJune 11, 2024 -
Optimization and Application of Endosomal Escape Vehicle (EEV™) Cell-Penetrating Peptides for Enhanced Delivery of Oligonucleotides and Genomic Medicines
- By: Leo Ziqing Qian, PhD, Co-Founder & Vice President, Discovery Research, Entrada Therapeutics
- At: TIDES USA 2024
- On: May 16, 2024
DownloadMay 16, 2024 -
The Endosomal Escape Vehicle Platform Enhances Lipid Nanoparticle-mediated Delivery of Genomic Medicines
- By: Leo Ziqing Qian, PhD, Co-Founder & Vice President, Discovery Research, Entrada Therapeutics
- At: ASGCT 27TH Annual Meeting
- On: May 7, 2024
DownloadMay 7, 2024 -
Optimization and Application of the Endosomal Escape Vehicle (EEV™) Platform for Enhanced Delivery of Oligonucleotides to Skeletal and Cardiac Muscle
- By: Xiang Li, PhD, Director, Discovery Research, Entrada Therapeutics
- At: ASGCT 27TH Annual Meeting
- On: May 7, 2024
DownloadMay 7, 2024 -
Exon Skipping and Dystrophin Production with Endosomal Escape Vehicle (EEV™) - Oligonucleotide Conjugates in Preclinical Models of Duchenne Muscular Dystrophy
- By: Mahasweta Girgenrath, PhD, Vice President Neuromuscular, Entrada Therapeutics
- At: 8th International Myology Congress
- On: April 22, 2024
DownloadApril 22, 2024